FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer

NCT00578201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer Stage III

Interventions

DRUG: radiochemotherapy,combination Cetuximab-FOLFOX

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]